3β-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer

Article

Abstract: Prostate cancer usually responds to androgen deprivation therapy, although the response in metastati

Palabras claves:

Autores:

Evaul K., Li R., Papari-Zareei M., Richard J. Auchus, Sharifi N.

Fuentes:

scopus